"Our mission remains driven by two goals:
to improve patient safety and enhance quality of care."
DCASIP Director, Dr. Dev Anderson, et al, tested two core antimicrobial stewardship interventions at four community hospitals in NC. The details of the study can be found on JAMA Network Open. They found that one of the care interventions -- post-prescription audit and review by a pharmacist after 72 house of therapy -- was feasible in facilities with limited resources and little to no antimicrobial stewardship expertise.
April Dyer and Rebkah Moehring were featured on The ICHE Podcast, hosted by the journal Infection Control & Hospital Epidemiology, to discuss their paper "Total duration of antimicrobial therapy resulting from inpatient hospitalization." The paper was published in August issue of ICHE and is available here.
Founder Dr. Dan Sexton provided an editorial commentary for The Journal of Infectious Diseases that was e-published July 3, 2019.
"Even experienced physicians and epidemiologists have difficulty consistently and accurately confirming or excluding a diagnosis of spotted fever group rickettsioses (SFGR). As a result, both underdiagnosis and overdiagnosis of SFGR are unresolved clinical and epidemiologic problems. The report by Straily et al in this issue of The Journal of Infectious Diseases sheds light on the pitfalls of using a single serologic assay to diagnose or classify a case of SFGR."
On May 28, 2019 a paper that DASON staff, DCASIP faculty, and Duke Health Pharmacy staff have been working on was published in Infection Control & Hospital Epidemiology. The purpose of this work was to assess the feasibility of electronic data capture of post discharge durations and evaluate total durations of anyimicrobial exposure related to inpatient hospital stays.
To read the full publication, click here.
Antimicrobial resistance is a major challenge for modern healthcare. The Duke Center for Antimicrobial Stewardship and Infection Prevention includes a unique portfolio of programs to fight this growing problem. We at CDC look forward to continuing our collaborations with Duke to help protect patients.
Dr Anderson and colleagues in the Duke Center for Antimicrobial Stewardship and Infection Prevention are world leaders in the important and essential fight to prevent infections and antimicrobial resistance. They are truly providing the 'guiding lights' and leadership for all to follow in this mission.
The Duke Center for Antimicrobial Stewardship and Infection Prevention is an important source for education and programmatic support for hospitals in the Southeastern US. In addition, their research on the epidemiology of multidrug-resistant pathogens and enhancing antibiotic stewardship is of high quality and public health value. I look forward to collaborating with Dr. Anderson and his expert colleagues for years to come.
